Phase II studies of different schedules and doses of the farnesyltransferase inhibitor tipifarnib (R115777, zarnestra) for patients of age 70 or older with previously untreated acute myeloid leukemia (AML): North American intergroup study S0432.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Erba, HP; Kopecky, KJ; Kirschbaum, MH; Tallman, MS; Larson, RA; Willman, CL; Slovak, ML; Gundacker, HM; Appelbaum, FR

Published Date

  • February 1, 2008

Published In

Volume / Issue

  • 87 /

Start / End Page

  • S57 - S59

Published By


  • 3

Electronic International Standard Serial Number (EISSN)

  • 1432-0584

International Standard Serial Number (ISSN)

  • 0939-5555